Entity Common Stock, Shares Outstanding of Outlook Therapeutics, Inc. from 23 Jun 2016 to 16 Dec 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Outlook Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 23 Jun 2016 to 16 Dec 2025.
  • Outlook Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 16 Dec 2025 was 64,114,399, a 157% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Outlook Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 64,114,399 +39,208,764 +157% 16 Dec 2025 10-K 19 Dec 2025 2025 FY
Q2 2025 44,419,529 +20,763,893 +88% 11 Aug 2025 10-Q 14 Aug 2025 2025 Q3
Q1 2025 33,568,023 +10,162,386 +43% 12 May 2025 10-Q 15 May 2025 2025 Q2
Q4 2024 24,905,635 -235,351,882 -90% 24 Dec 2024 10-K 27 Dec 2024 2024 FY
Q2 2024 23,655,636 -236,589,381 -91% 12 Aug 2024 10-Q 14 Aug 2024 2024 Q3
Q1 2024 23,405,637 -233,261,157 -91% 13 May 2024 10-Q 15 May 2024 2024 Q2
Q4 2023 260,257,517 +32,051,554 +14% 10 Jan 2024 10-K/A 24 Jan 2024 2023 FY
Q2 2023 260,245,017 +34,100,383 +15% 10 Aug 2023 10-Q 14 Aug 2023 2023 Q3
Q1 2023 256,666,794 +30,724,075 +14% 10 May 2023 10-Q 15 May 2023 2023 Q2
Q4 2022 228,205,963 +3,945,361 +1.8% 27 Dec 2022 10-K 29 Dec 2022 2022 FY
Q2 2022 226,144,634 +50,803,461 +29% 08 Aug 2022 10-Q 10 Aug 2022 2022 Q3
Q1 2022 225,942,719 +52,336,912 +30% 11 May 2022 10-Q 13 May 2022 2022 Q2
Q4 2021 224,260,602 +97,077,493 +76% 20 Dec 2021 10-K 23 Dec 2021 2021 FY
Q2 2021 175,341,173 +48,158,064 +38% 11 Aug 2021 10-Q 13 Aug 2021 2021 Q3
Q1 2021 173,605,807 +82,228,159 +90% 12 May 2021 10-Q 14 May 2021 2021 Q2
Q4 2020 127,183,109 +97,079,936 +322% 18 Dec 2020 10-K 23 Dec 2020 2020 FY
Q2 2020 127,183,109 +98,949,625 +350% 12 Aug 2020 10-Q 14 Aug 2020 2020 Q3
Q1 2020 91,377,648 +69,278,018 +313% 13 May 2020 10-Q 15 May 2020 2020 Q2
Q4 2019 30,103,173 -54,987,889 -65% 16 Dec 2019 10-K 19 Dec 2019 2019 FY
Q2 2019 28,233,484 -43,964,984 -61% 12 Aug 2019 10-Q 14 Aug 2019 2019 Q3
Q1 2019 22,099,630 -10,232,938 -32% 13 May 2019 10-Q 15 May 2019 2019 Q2
Q4 2018 85,091,062 +59,560,335 +233% 14 Dec 2018 10-K 18 Dec 2018 2018 FY
Q2 2018 72,198,468 +47,522,103 +193% 10 Aug 2018 10-Q 14 Aug 2018 2018 Q3
Q1 2018 32,332,568 +7,879,555 +32% 14 May 2018 10-Q 15 May 2018 2018 Q2
Q4 2017 25,530,727 +1,951,785 +8.3% 27 Dec 2017 10-K 29 Dec 2017 2017 FY
Q2 2017 24,676,365 +1,873,587 +8.2% 11 Aug 2017 10-Q 14 Aug 2017 2017 Q3
Q1 2017 24,453,013 11 May 2017 10-Q 15 May 2017 2017 Q2
Q4 2016 23,578,942 28 Dec 2016 10-K 29 Dec 2016 2016 FY
Q2 2016 22,802,778 23 Jun 2016 10-Q 27 Jun 2016 2016 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.